Search
for
Sort by
Research 751–780 of 1000+
- Metabolic risk in PCOS: phenotype and adiposity impact
- Review of quality of life studies in women with alopecia
- JAK inhibitors and alopecia areata
- The Enigma of the Stigma of Hair Loss: Why is Cancer-Treatment Related Alopecia so Traumatic for Women?
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- The efficacy of 3% minoxidil vs. combined 3% minoxidil and Korean red ginseng in treating female pattern alopecia
- Non-hemorrhage-related adverse effects of rivaroxaban
- Isoniazid-induced alopecia
- Proton Affinitive Derivatization for Highly Sensitive Determination of Testosterone and Dihydrotestosterone in Saliva Samples by LC-ESI-MS/MS
- Interconnected PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair Loss Conditions
- The Effects of Smoking on Hair Health: A Systematic Review
- Smoker’s Mustache Revisited: Upper Lip Hair Yellow Discoloration Associated With Tobacco
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Treatment of female sexual dysfunction in postmenopausal women—What is the evidence?
- Hand Pilomatrixoma: A Rare Localization
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- Cronkhite-Canada syndrome: A rare disease presenting with dermatological and gastrointestinal manifestations
- NEW YORK DERMATOLOGICAL SOCIETY
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Baricitinib Provides Significant Hair Regrowth In Adolescents With Severe Alopecia Areata: 52-Week Efficacy and Safety Results From A Phase 3 Randomized, Controlled Trial
- Peroxisome Proliferator Activated Receptors Gamma Serum levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case Control Study
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review
- Polycystic ovarian syndrome
- A prospective observational study on drug safety monitoring and Pharmacoeconomics in patients with locally advanced unresectable NSCLC in a tertiary care hospital
- PLAU and SerpinB2 role in apoptosis in leprosy
- Pityriasis rubra pilaris unveiling a case of a new onset hepatitis C infection